Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2001American Medical Association
Therapeutic misconceptions are common among patients even after they sign informed consent statements asserting that they fully comprehend the pros and cons of clinical trials, said Boston researchers in a study appearing in the November 24 issue of The Lancet.
In the study, which was conducted at Dana-Farber Cancer Institute, Massachusetts General Hospital, and Brigham and Women's Hospital, 205 adult cancer patients who had recently enrolled in phase 1, 2, and 3 clinical trials in Boston completed questionnaires about their understanding of the studies.
Mitka M. Not-so-Informed Consent. JAMA. 2001;286(24):3071. doi:10.1001/jama.286.24.3071-JQU10011-5-1